[1] Jung HS, Kwon BS, Lee SW.Tumor-specific gene delivery using RNA-targeting Tetrahymena group I intron. Biotechnol Lett. 2005;27(8):567-574.
[2] Wang Y, Zeng B, Li X.Expression of human calcitonin by microencapsulated recombinant myoblasts. Biotechnol Lett.2006;28(18):1453-1458.
[3] Friedenstein AJ,Piatetzky-Shapiro II,Petrakova KV.Osteogenesisin transplants of bone marrow cells. J Embryol Exp Morphol.1966;16(3):381-390.
[4] Pittenger MF,Mackay AM,Beck SC,et al.Multilineage potential of adult human mesenchymal stem cells. Science.1999; 284(5411):143-147.
[5] Abdallah BM, Kassem M. Human mesenchymal stem cells: from basic biology to clinical applications. Gene Ther. 2008; 15:109-116.
[6] Verbruggen G, Wang J, Wang L, et al. Analysis of chondrocyte functional markers and pericellular matrix components by flow cytometry. Methods Mol Med. 2004;100: 183-208.
[7] Bianco P, Riminucci M, Gronthos S, et al. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells. 2001;19(3):180-192.
[8] Javazon EH, Beggs KJ, Flake AW. Mesenchymal stem cells: paradoxes of passaging. Exp Hematol. 2004;32(5):414-425.
[9] de Boer TN, Huisman AM, Polak AA, et al.The chondroprotective effect of selective COX-2 inhibition in osteoarthritis: ex vivo evaluation of human cartilage tissue after in vivo treatment. Osteoarthritis Cartilage. 2009;17:482-488.
[10] Kumagai K, Kubo M, Imai S,et al.The COX-2 Selective Blocker Etodolac Inhibits TNFalpha-Induced Apoptosis in Isolated Rabbit Articular Chondrocytes.Int J Mol Sci. 2013;14:19705-19715.
[11] Alvarez-Soria MA, Herrero-Beaumont G, et al. Long-term NSAID treatment directly decreases COX-2 and mPGES-1 production in the articular cartilage of patients with osteoarthritis. Osteoarthritis Cartilage. 2008;16:1484-1493.
[12] Alvarez-Soria MA, Largo R, Santillana J,et al.Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac. Ann Rheum Dis. 2006;65:998-1005.
[13] Depre M, Ehrich E, Van Hecken A,et al. Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans. Eur J Clin Pharmacol. 2000;56:167-174.
[14] Depboylu C, Weihe E, Eiden LE. COX1 and COX2 expression in non-neuronal cellular compartments of the rhesus macaque brain during lentiviral infection. Neurobiol Dis. 2011;42:108-115.
[15] Harrison JR, Lorenzo JA, Kawaguchi H,et al.Stimulation of prostaglandin E2 production by interleukin-1 alpha and transforming growth factor alpha in osteoblastic MC3T3-E1 cells.J Bone Miner Res. 1994;9:817-23.
[16] Rodan SB, Rodan GA, Simmons HA,et al. Bone resorptive factor produced by osteosarcoma cells with osteoblastic features is PGE2. Biochem Biophys Res Commun. 1981;102:1358-1365.
[17] Debnath T, Kim da H, Lim BO. Natural products as a source of anti-inflammatory agents associated with inflammatory bowel disease. Molecules. 2013;18:7253-7270.
[18] Li ZG, Wang XY, Chang JL, et al. The establishment of supramolecular immunobead real-time PCR and the identification of Cox-2 as a metastasis-related marker in colorectal carcinoma. Oncol Rep. 2012;28:977-84.
[19] Wakefield AP, Ogborn MR, Ibrahim N, et al. A dietary conjugated linoleic acid treatment that slows renal disease progression alters renal cyclooxygenase-2-derived prostanoids in the Han: SPRD-cy rat. J Nutr Biochem. 2012; 23:908-914.
[20] Reverte V, Tapia A, Moreno JM,et al.Renal effects of prolonged high protein intake and COX2 inhibition on hypertensive rats with altered renal development. Am J Physiol Renal Physiol. 2011;301:F327-33.
[21] Ulivi V,Lenti M,Gentili C,et al.Anti-inflammatory activity of monogalactosyldiacylglycerol in human articular cartilage in vitro: activation of an anti-inflammatory cyclooxygenase-2 (COX-2) pathway.Arthritis Res Ther. 2011;13:R92.
[22] Hagmann S, Moradi B, Frank S, et al.Different culture media affect growth characteristics, surface marker distribution and chondrogenic differentiation of human bone marrow-derived mesenchymal stromal cells. BMC Musculoskelet Disord. 2013; 14:223.
[23] 刘伟,刘萌,祝劲松,等.人骨髓间充质干细胞的体外培养、鉴定及成骨分化[J].中国组织工程研究,2012,16(14):2515-2519.
[24] Wu B, Ma X, Zhu D,et al. Lentiviral delivery of biglycan promotes proliferation and increases osteogenic potential of bone marrow-derived mesenchymal stem cells in vitro. J Mol Histol. 2013;44:423-31.
[25] Ricks DM, Kutner R, Zhang XY,et al. Optimized lentiviral transduction of mouse bone marrow-derived mesenchymal stem cells. Stem Cells Dev. 2008;17:441-50.
[26] Lee CI, Kohn DB, Ekert JE, et al. Morphological analysis and lentiviral transduction of fetal monkey bone marrow-derived mesenchymal stem cells. Mol Ther. 2004;9:112-23.
[27] Liu Z, Wu XZ, Song R,et al. RNAi-mediated knockdown of cyclooxygenase2 inhibits the growth and migration of SaOS2 human osteosarcoma cells. Zhonghua Yi Xue Za Zhi. 2013;93: 1028-1031. |